GlassScriptPhysician profile
John H Susz
NPI 1790736734
$14,066.19
in general payments reported to CMS, 2019-2025
11 companies · $2,933 in 2025
The $2,933 reported for 2025 was more than what 93% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,368 · 2020: $840 · 2021: $1,974 · 2022: $4,730 · 2023: $588 · 2024: $633 · 2025: $2,933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,356 · Travel and Lodging: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,355.69 |
| Travel and Lodging | $1,798.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $9,018.04 | 2019-2025 | |
| Organogenesis INC. | $1,677.51 | 2019-2025 | Puraply Wound Matrix, Puraply, Affinity |
| Arthrex, INC. | $1,567.68 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $815.55 | 2022 | |
| Smith+Nephew, INC. | $629.60 | 2019-2025 | Grafix Pl, Stravix Pl |
| Osiris Therapeutics INC. | $149.78 | 2019 | |
| Abbott Laboratories | $78.02 | 2019 | |
| Bioventus LLC | $48.53 | 2019-2022 | |
| Stryker Corporation | $35.43 | 2025 | Easyfuse, Ortholoc 3di, Swanson |
| Extremity Medical | $31.97 | 2024 | |
| Melinta Therapeutics, LLC | $14.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Susz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.